Skip to main content
Clinical Trials/NCT02741206
NCT02741206WithdrawnNot Applicable

Bellevue ROSE: Preventing Postpartum Depression in Prenatal Care

NYU Langone Health1 site in 1 countryStarted: June 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
Depression severity measured by Patient Health Questionnaire (PHQ-9)

Study Overview

Brief Summary

This is randomized control trial of a brief intervention called Bellevue ROSE (Reach Out Stay Strong Essentials). Bellevue ROSE is a manualized and highly structured interpersonal intervention that provides women with psycho-education about maternal depression and strategies for strengthening social support and connectedness. Investigators use motivational interviewing strategies to improve treatment compliance and resource acquisition

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •English speaking
  • •Women who score between 5-19 on the PHQ-9 and >23 on the ANRQ

Exclusion Criteria

  • •Women who score <5 or >19 on the PHQ-9
  • •Women who are currently suicidal, active substance users, currently experiencing domestic violence, or have a current or past history of bipolar or psychotic disorder diagnosis.
  • •Women who are currently in treatment for psychotherapy.
  • •Unable to speak and/or understand English proficiently
  • •Unable to provide informed consent

Arms & Interventions

High Risk PTSD Group 1

Active Comparator

Forty women who are eligible for the study will be randomized into either the Bellevue ROSE intervention (treatment group) or a psycho-education session and usual, standard of care (control group 1)

Intervention: Bellevue ROSE Intervention (Behavioral)

High Risk PTSD Group 1

Active Comparator

Forty women who are eligible for the study will be randomized into either the Bellevue ROSE intervention (treatment group) or a psycho-education session and usual, standard of care (control group 1)

Intervention: Psycho-education session and usual, Standard of care Control (Behavioral)

High Risk PTSD Group 2

Active Comparator

Forty women who are eligible for the study will be randomized into either the Bellevue ROSE intervention (treatment group) or a psycho-education session and usual, standard of care (control group 1)

Intervention: Bellevue ROSE Intervention (Behavioral)

High Risk PTSD Group 2

Active Comparator

Forty women who are eligible for the study will be randomized into either the Bellevue ROSE intervention (treatment group) or a psycho-education session and usual, standard of care (control group 1)

Intervention: Psycho-education session and usual, Standard of care Control (Behavioral)

Low Risk PTSD Control

Experimental

Twenty additional women, who are at lower risk and thus not eligible for randomization, will also receive one psycho-education session and usual care (control group 2).

Intervention: One Psycho-education session and usual, standard of care Control (Behavioral)

Outcomes

Primary Outcomes

Depression severity measured by Patient Health Questionnaire (PHQ-9)

Time Frame: 6 Months

Measure of perceived social support measured by Multidimensional Scale of Perceived Social Support (MSPSS)

Time Frame: 6 Months

Measure of stress using Perceived Stress Index (PSS)

Time Frame: 6 Months

Parenting Practices and treatment assessed by Parenting Practices and Treatment Questionnaire

Time Frame: 6 Months

Measure of psycho social risk assessment according to Adapted antenatal Risk Questionnaire (ANRQ)

Time Frame: Screening

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials